| Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD) (NCT04959188) | National Cancer Institute (NCI) | 2021-09-09 |
| The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis (NCT04638517) | The University of Queensland | 2021-09-07 |
| Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures (NCT04232085) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-12 |
| Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders (NCT03579875) | Masonic Cancer Center, University of Minnesota | 2018-11-13 |
| Familial Investigations of Childhood Cancer Predisposition (NCT03050268) | St. Jude Children's Research Hospital | 2017-04-06 |
| Investigation of the Genetics of Hematologic Diseases (NCT02720679) | St. Jude Children's Research Hospital | 2016-06-17 |
| Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia (NCT02162420) | Masonic Cancer Center, University of Minnesota | 2015-01-10 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases (NCT01917708) | Emory University | 2014-01-01 |
| Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita (NCT01659606) | Boston Children's Hospital | 2012-07-01 |
| Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation (NCT01319851) | Emory University | 2010-09-01 |
| Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita (NCT01001598) | Boston Children's Hospital | 2009-11-01 |
| Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA (NCT00455312) | Masonic Cancer Center, University of Minnesota | 2007-08-01 |
| Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment (NCT00499070) | University Hospital Freiburg | 2007-01-01 |
| Cancer in Inherited Bone Marrow Failure Syndromes (NCT00027274) | National Cancer Institute (NCI) | 2001-11-28 |
| Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes (NCT00004787) | National Center for Research Resources (NCRR) | 1994-12-01 |
| Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts (NCT06731036) | University of Florida | |